Dialysis Patients Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting dialysis patients clinical trials across 10 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Bangkok, Thailand, Beijing, Beijing Municipality, China, Hawalli, Kuwait. Updated daily from ClinicalTrials.gov.


Dialysis Patients Trials at a Glance

12 actively recruiting trials for dialysis patients are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Bangkok, Beijing, and Hawalli. Lead sponsors running dialysis patients studies include Chulalongkorn University, Department of Renal Medicine, and Arbor Research Collaborative for Health.

Browse dialysis patients trials by phase

About Dialysis Patients Clinical Trials

Looking for clinical trials for Dialysis Patients? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dialysis Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dialysis Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Using a Hypotension Prediction Index to Prevent Low Blood Pressure During Dialysis in ICU Patients

Intradialytic HypotensionHemodialysis PatientsIntensive Care Unit ICU
Chulalongkorn University46 enrolled1 locationNCT07179705
Recruiting
Not Applicable

Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients

haemodialysis patientsBlockage of Tunnelled Central Venous Access DevicePulsatile Flushing Technique
Queen Elizabeth Hospital, Hong Kong591 enrolled1 locationNCT07567456
Recruiting

Comparisons Of Biochemical And Clinical Outcomes Of Hemodialysis Patients Treated With Middle Cut-Off Dialyzers Versus High-Flux Hemodialysis Or Hemodiafiltration

Dialysis PatientsESKD
Arbor Research Collaborative for Health1,000 enrolled1 locationNCT07561424
Recruiting
Not Applicable

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2

AKI - Acute Kidney InjuryAKIDialysis Patients
University of California, San Francisco40 enrolled1 locationNCT07106151
Recruiting
Not Applicable

A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial

Chronic Kidney DiseaseEnd Stage Renal Disease (ESRD)Hemodialysis Patients+1 more
Mohammad Arian72 enrolled1 locationNCT07361146
Recruiting
Not Applicable

Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients

Dialysis Patients
University of Avignon108 enrolled2 locationsNCT07269379
Recruiting

Search About Contributing Factors That Leading to Intradialytic Hypertension in Hemodialysis Patients

Intradialytic Hypertension in Hemodialysis Patients
Sohag University50 enrolled1 locationNCT07069491
Recruiting

AI-Driven Prediction of Dialysis Outcome With EHR

Dialysis Patients
The Eye Hospital of Wenzhou Medical University1,000,000 enrolled1 locationNCT06791447
Recruiting
Phase 4

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
The People's Hospital of Gaozhou40 enrolled1 locationNCT06365541
Recruiting
Phase 3

The effect of lower salt exposure on the cardiac structure and function of patients on home haemodialysis

Cardiovascular outcomes in dialysis patients
The Centre for Clinical Research and effective practice (CCRep), registered with the New Zealand Charities Commission (ref# CC21537)118 enrolled1 locationACTRN12611000975998
Recruiting

End-of-Life Care in End Stage Renal Disease: Integration of an advance care planning process

pre-dialysis (clinically expected to start dialysis within 12 months) and incident dialysis patients
University Hospital Foundation200 enrolled1 locationACTRN12610000782033
Recruiting

An observational Study in Optimising Intraperitoneal Gentamicin in peritoneal dialysis patients with peritonitis

Gentamicin dosing in Peitonitis in peritoneal dialysis patients
Department of Renal Medicine30 enrolled1 locationACTRN12609000446268